Jeff Geschwind, MD: Bridging Innovation and Patient Care Jeff Geschwind, MD, uniquely bridges cutting-edge research and clinical practice. His roles from NAMSA to USA Clinics Group ensure that scientific innovations are translated into real-world, effective cancer care for patients. https://www.academia.edu/143398007/Targeting_Tumor_Glycolysis_A_Promising_Frontier_in_Cancer_Therapy